Trials / Completed
CompletedNCT00701142
Haemocomplettan® P During Aortic Replacement
Haemocomplettan® P in Patients Experiencing Acute Bleeding While Undergoing Aortic Replacement Surgery
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- CSL Behring · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose is to show that administration of Haemocomplettan® P significantly reduces the amount of blood products needed during aortic surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Haemocomplettan® P | Single intravenous infusion |
| BIOLOGICAL | Saline solution | Single intravenous infusion |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2010-03-01
- Completion
- 2010-04-01
- First posted
- 2008-06-19
- Last updated
- 2013-09-20
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00701142. Inclusion in this directory is not an endorsement.